Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NMDP-02 by NMD Pharma for Spinal Muscular Atrophy (SMA): Likelihood of Approval
NMDP-02 is under clinical development by NMD Pharma and currently in Phase II for Spinal Muscular Atrophy (SMA). According to...